← Leaderboards
Claus Schneider
Vanderbilt University
$9,629,126
Attributed
$9,629,126
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $824.6K · FY2007–25$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,629,126 · 5
By mechanism
R01$7,577,424 · 3
R35$1,900,382 · 1
R03$151,320 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Bethann M McLaughlin$3,074,533
Others in their field
Top investigators on “Inflammatory”
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Edward A Dennis · University Of California, San Diego$72,701,136
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Randall J Bateman · Washington University$62,939,456
- Paul M. Ridker · Brigham And Women'S Hospital$56,179,451
- Keri Hammel · The Emmes Company, Llc$53,700,408
Research focus
InflammatoryProstaglandinsInflammationEicosanoidsPharmaceutical PreparationsAnabolismPathway InteractionsIn VitroLeukotrienesBaseTissuesEnzymesMetabolismAnti-InflammatoryIn VivoArachidonic AcidsAspirinLipoxygenaseProstaglandin D2Prostaglandin-Endoperoxide SynthaseMediator Of Activation ProteinBiologicalAnti-Inflammatory AgentsMalignant Neoplasms
Grant awards (31)
Novel pathways in eicosanoid biosynthesis and metabolism$473,882
R35 · FY2025 · GM · contact PI
Novel pathways in eicosanoid biosynthesis and metabolism$475,500
R35 · FY2024 · GM · contact PI
Novel pathways in eicosanoid biosynthesis and metabolism$475,500
R35 · FY2023 · GM · contact PI
Novel pathways in eicosanoid biosynthesis and metabolism$475,500
R35 · FY2022 · GM · contact PI
Convergence of the Cox-2 and 5-Lipoxygenase Pathways$312,510
R01 · FY2021 · GM · contact PI
Convergence of the Cox-2 and 5-Lipoxygenase Pathways$312,510
R01 · FY2020 · GM · contact PI
Novel Pathways of Eicosanoid Metabolism$310,432
R01 · FY2020 · GM · contact PI
Convergence of the Cox-2 and 5-Lipoxygenase Pathways$312,510
R01 · FY2019 · GM · contact PI
Novel Pathways of Eicosanoid Metabolism$310,425
R01 · FY2019 · GM · contact PI
Novel Pathways of Eicosanoid Metabolism$54,727
R01 · FY2019 · GM · contact PI
Convergence of the Cox-2 and 5-Lipoxygenase Pathways$54,727
R01 · FY2019 · GM · contact PI
Convergence of the Cox-2 and 5-Lipoxygenase Pathways$326,760
R01 · FY2018 · GM · contact PI
Novel Pathways of Eicosanoid Metabolism$310,419
R01 · FY2018 · GM · contact PI
Oxidative activation of the dietary cancer chemopreventive agent curcumin$409,921
R01 · FY2017 · AT · contact PI
Novel Pathways of Eicosanoid Metabolism$321,669
R01 · FY2017 · GM · contact PI
Oxidative activation of the dietary cancer chemopreventive agent curcumin$522,897
R01 · FY2016 · AT · contact PI
Oxidative activation of the dietary cancer chemopreventive agent curcumin$420,429
R01 · FY2015 · AT · contact PI
Convergence of the Cox-2 and 5-Lipoxygenase Pathways$313,560
R01 · FY2015 · GM · contact PI
Oxidative activation of the dietary cancer chemopreventive agent curcumin$431,798
R01 · FY2014 · AT · contact PI
Convergence of the Cox-2 and 5-Lipoxygenase Pathways$313,560
R01 · FY2014 · GM · contact PI
Oxidative activation of the dietary cancer chemopreventive agent curcumin$448,716
R01 · FY2013 · AT · contact PI
Convergence of the Cox-2 and 5-Lipoxygenase Pathways$302,585
R01 · FY2013 · GM · contact PI
Pharmacokinetics and Metabolism of Oxidized Curcumin$73,320
R03 · FY2013 · CA · contact PI
Convergence of the Cox-2 and 5-Lipoxygenase Pathways$313,560
R01 · FY2012 · GM · contact PI
Pharmacokinetics and Metabolism of Oxidized Curcumin$78,000
R03 · FY2012 · CA · contact PI
Convergence of the COX-2 and 5-lipoxygenase pathways$285,847
R01 · FY2011 · GM · contact PI
Convergence of the COX-2 and 5-lipoxygenase pathways$288,734
R01 · FY2010 · GM · contact PI
Convergence of the COX-2 and 5-lipoxygenase pathways$291,650
R01 · FY2009 · GM · contact PI
Convergence of the COX-2 and 5-lipoxygenase pathways$55,053
R01 · FY2009 · GM · contact PI
Convergence of the COX-2 and 5-lipoxygenase pathways$281,485
R01 · FY2008 · GM · contact PI
Convergence of the COX-2 and 5-lipoxygenase pathways$270,940
R01 · FY2007 · GM · contact PI